Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320071061> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4320071061 endingPage "139" @default.
- W4320071061 startingPage "130" @default.
- W4320071061 abstract "Introduction. The main treatment option for chronic bacterial prostatitis (CBP) is antimicrobial therapy. However, in connection with the steady increase in resistance to antimicrobial drugs and the high rate of failure in the treatment of such patients, it seems relevant to study new approaches to the treatment of this disease. Materials and methods. The review is based on articles published over the past 10 years (2011-2021) in scientific peer-reviewed journals included in the PubMed databases (https://www.ncbi.nlm.nih.gov/pubmed/) and the Scientific Electronic Library Elibrary.ru (https://elibrary.ru/). The search was carried out for the following keywords: «prostatitis», «chronic prostatitis», «chronic bactrial prostatitis», «chronic infectious prostatitis». At the first stage, 477 sources were found that were relevant to the topic of the review, of which 70 articles were selected for the final version of the review. Results. Oral antibiotic therapy remains the mainstay of treatment for CBP. There is a tendency towards an increase in resistance to traditionally used antimicrobial agents (fluoroquinolones, trimethoprim-sulfamethoxazole, etc.). In this regard, the possibilities of alternative antibacterial drugs (fosfomycin, etc.) and other methods of treatment are actively used and are being studied: direct administration of antimicrobial drugs into the prostate gland, chronic oral antibiotic prophylaxis, phage therapy and surgical interventions. An important role in the treatment of CBP is assigned to other pharmacological groups of drugs and non-drug methods of treatment (primarily physiotherapeutic methods). Conclusion. Many therapies that are used in addition to or instead of oral antibiotic therapy still cannot be recommended for use in general clinical practice, since there is currently a lack of sufficient evidence of their effectiveness and safety. Therefore, considering the existing problems of treating such patients, the need to continue studies to assess the possibilities of new promising approaches to the treatment of CBP remains relevant." @default.
- W4320071061 created "2023-02-12" @default.
- W4320071061 creator A5007758590 @default.
- W4320071061 creator A5022041149 @default.
- W4320071061 date "2022-06-25" @default.
- W4320071061 modified "2023-10-01" @default.
- W4320071061 title "Modern approaches to the treatment of chronic bacterial prostatitis." @default.
- W4320071061 doi "https://doi.org/10.29188/2222-8543-2022-15-2-130-139" @default.
- W4320071061 hasPublicationYear "2022" @default.
- W4320071061 type Work @default.
- W4320071061 citedByCount "0" @default.
- W4320071061 crossrefType "journal-article" @default.
- W4320071061 hasAuthorship W4320071061A5007758590 @default.
- W4320071061 hasAuthorship W4320071061A5022041149 @default.
- W4320071061 hasBestOaLocation W43200710611 @default.
- W4320071061 hasConcept C121608353 @default.
- W4320071061 hasConcept C126322002 @default.
- W4320071061 hasConcept C177713679 @default.
- W4320071061 hasConcept C178790620 @default.
- W4320071061 hasConcept C185592680 @default.
- W4320071061 hasConcept C2776235491 @default.
- W4320071061 hasConcept C2778897966 @default.
- W4320071061 hasConcept C2779529836 @default.
- W4320071061 hasConcept C2780524745 @default.
- W4320071061 hasConcept C4937899 @default.
- W4320071061 hasConcept C501593827 @default.
- W4320071061 hasConcept C71924100 @default.
- W4320071061 hasConcept C86803240 @default.
- W4320071061 hasConcept C89423630 @default.
- W4320071061 hasConcept C94665300 @default.
- W4320071061 hasConceptScore W4320071061C121608353 @default.
- W4320071061 hasConceptScore W4320071061C126322002 @default.
- W4320071061 hasConceptScore W4320071061C177713679 @default.
- W4320071061 hasConceptScore W4320071061C178790620 @default.
- W4320071061 hasConceptScore W4320071061C185592680 @default.
- W4320071061 hasConceptScore W4320071061C2776235491 @default.
- W4320071061 hasConceptScore W4320071061C2778897966 @default.
- W4320071061 hasConceptScore W4320071061C2779529836 @default.
- W4320071061 hasConceptScore W4320071061C2780524745 @default.
- W4320071061 hasConceptScore W4320071061C4937899 @default.
- W4320071061 hasConceptScore W4320071061C501593827 @default.
- W4320071061 hasConceptScore W4320071061C71924100 @default.
- W4320071061 hasConceptScore W4320071061C86803240 @default.
- W4320071061 hasConceptScore W4320071061C89423630 @default.
- W4320071061 hasConceptScore W4320071061C94665300 @default.
- W4320071061 hasIssue "2" @default.
- W4320071061 hasLocation W43200710611 @default.
- W4320071061 hasOpenAccess W4320071061 @default.
- W4320071061 hasPrimaryLocation W43200710611 @default.
- W4320071061 hasRelatedWork W2040770664 @default.
- W4320071061 hasRelatedWork W2090214750 @default.
- W4320071061 hasRelatedWork W2787918924 @default.
- W4320071061 hasRelatedWork W2912218605 @default.
- W4320071061 hasRelatedWork W2969625921 @default.
- W4320071061 hasRelatedWork W3044092742 @default.
- W4320071061 hasRelatedWork W3163962061 @default.
- W4320071061 hasRelatedWork W4282977029 @default.
- W4320071061 hasRelatedWork W4386624930 @default.
- W4320071061 hasRelatedWork W2524329708 @default.
- W4320071061 hasVolume "15" @default.
- W4320071061 isParatext "false" @default.
- W4320071061 isRetracted "false" @default.
- W4320071061 workType "article" @default.